Patents
Patents for C07C 251 - Compounds containing nitrogen atoms doubly- bound to a carbon skeleton (9,928)
06/2005
06/22/2005EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908783 Method of doping organic semiconductors with quinonediimine derivatives
06/16/2005WO2005021562A3 Phospinite-imidazolines and metal complexes thereof
06/15/2005EP1541548A1 Oxamidination process of carbonyl compounds
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005CN1627939A Bicyclic CB2 cannabinoid receptor ligands
06/15/2005CN1626558A Catalysts for olefin polymerization
06/14/2005US6906223 Method for the production of trioxime derivatives
06/14/2005US6906197 Process for the preparation of optically active amines or salts thereof
06/14/2005US6905999 Coordination polymerization catalyst
06/14/2005US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
06/14/2005CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners
06/09/2005WO2004093207A3 Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures
06/09/2005WO2003101938A8 Oxamidination process of carbonyl compounds
06/09/2005US20050124824 Process for the preparation of aryl hydrazone and aryl hydrazine
06/09/2005US20050124498 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
06/09/2005US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials
06/09/2005US20050121667 Method of doping organic semiconductors with quinonediimine derivatives
06/08/2005EP1538684A1 Process for doping organic semiconductors with derivatives of diiminoquinones
06/08/2005EP1537125A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1624948A Method of doping organic semiconductors with quinonediimine derivatives
06/08/2005CN1624591A Electron transferring compound and electrophotographic photoreceptor using the electron transferring compound
06/08/2005CN1205215C Oxime derivatives and the use thereof as latent acids
06/08/2005CN1205194C Biphenyl ether oxazolines and their use as pest-control agents
06/07/2005US6903237 Ectoparasitic insect pest controllers for animals and their usage
06/02/2005US20050119479 Contacting the oxime with an oxoacid, oxoacid salt, oxoacid ester, oxoacid amide or oxide of boron or phosphorus to increase thermal stability
06/02/2005US20050119326 Substituted aryloximes
06/02/2005US20050118519 Solubility in an alcohol solvent; synthesis involves reacting a cyclohexa-1,4-dien-3-one-6-al with an N-substituted phenylenediamine compound, solvent extraction to form an imine-containing cyclohexadienone compound
06/02/2005US20050118381 tetrakis(aminophenyl)phenylenediamine salts, having heat resistance and high solubility, used in near-infrared absorption filters and in optical recording media having colorfastness and photostability
05/2005
05/31/2005US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
05/31/2005US6900198 Salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide
05/26/2005WO2005047233A1 Novel herbicides
05/26/2005US20050113597 Ether cleavage of the corresponding phenyl ether derivatives in the presence of hydrogen chloride and an inert solvent and a catalyst selected from iron, indium, and halides, oxides and triflates thereof
05/26/2005US20050112400 Complex containing organometallic compound
05/25/2005EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates )
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1618792A Method of producing methoxyimino acetic amide
05/25/2005CN1618788A 2-carbonyl propionic acid salicylyl hydrazon rare earth compound and its preparation process and use
05/25/2005CN1203052C Process for production of cyclohexanone oxime
05/25/2005CN1203051C Process for preparing hydrazine
05/25/2005CN1203050C Process for production of cyclohexanone oxime
05/24/2005US6897275 Catalysts for olefin polymerization
05/24/2005US6897272 Diimine palladium or nickel complex having bulky substituents on the imine nitrogen having steric bulk sufficient to form a polymer with alpha-olefin, ethylene, or cyclopentene repeat units.
05/24/2005CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
05/19/2005WO2005044899A1 Prepolymer, prepolymer composition, high molecular weight polymer having structure containing hole and electrically insulating film
05/19/2005WO2005044782A1 Diimonium salt compound and use thereof
05/19/2005WO2005044781A1 Aromatic polyamine derivative
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2004078924A3 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/19/2005US20050107283 Volatile copper (II) complexes and reducing agents for deposition of copper films by atomic layer deposition
05/19/2005US20050106712 Gelling agent or a precursor to a gelling agent, a microsphere immobilized on a substrate, containing a yellow azo-methine dye; protein microarray
05/19/2005US20050106711 Cyan low fluorescence dye for coated optical bead random array DNA analysis
05/19/2005DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2543237A1 Diimonium salt compound and use thereof
05/18/2005CN1617948A Volatile copper(II) complexes for deposition of copper films by atomic layer deposition
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/18/2005CN1616465A Chiral copper complex and production processes thereof and using the same
05/18/2005CN1616416A Process for preparing aspartates
05/18/2005CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
05/17/2005US6894190 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
05/17/2005US6894172 Stereospecific catalysts comprising chelate compounds used for alkylation, reduction, cyclization, hydrogenation, amination, epoxidation, aldol or Michael condensations
05/17/2005US6894134 α-olefins and olefin polymers and processes therefor
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005WO2003074496A8 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
05/12/2005US20050101645 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth
05/11/2005EP1530097A2 Organophotoreceptor with charge transport material having a vinyl ether group
05/11/2005EP1230212B1 Process for the preparation of ketimines
05/11/2005CN1614494A Electro chromotropic apparatus containing hydrazone compound
05/11/2005CN1200928C Process for preparing cyclohexanone oxime
05/10/2005CA2097044C Cyclopentane- and -pentene-.beta.-amino acids
05/06/2005WO2005040096A1 Process for production of asymmetric alkyl compounds with alkali-treated solid carrier and alkali-treated solid carrier to be used in the process
05/05/2005US20050095517 electroconductive substrates having photoconductors comprising charge generating compound and charge transfer compounds having hydrazone and vinyl ether groups; electrostatics; printers; copiers
05/04/2005EP1527044A1 Polyaldimines
05/04/2005CN1612060A Organophotoreceptor with charge transport material having a vinyl ether group
05/04/2005CN1612057A Organophotoreceptor with charge transport material having fluorenone hydrazone groups
05/04/2005CN1199938C Azine compound, process for preparation thereof, nematic liquid crystal composition and use in liquid crystal display system
05/03/2005US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/03/2005US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
04/2005
04/28/2005WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005WO2005037773A1 Acylhydrazone derivatives and their use in the inhibition, regulation and/or modulation of the signal transduction of kinases
04/28/2005WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics
04/28/2005US20050090684 comprises salicylideneaminoalcohol via reacting optically active amino alcohol with 2-hydroxybenzaldehyde derivative
04/28/2005US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts
04/28/2005US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/28/2005CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005CA2542106A1 Acylhydrazone derivatives and their use in the inhibition, regulation and/or modulation of the signal transduction of kinases
04/28/2005CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics
04/27/2005CN1198829C Aluminium compounds for producing vinylic polymers
04/27/2005CN1198796C Process for preparing oxime
04/26/2005CA2194203C Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives
04/21/2005WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
04/21/2005WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration
04/20/2005EP1524262A1 Inhibitors of histone deacetylase
04/20/2005EP1523778A2 Heteroatom-containing diamondoid transistors
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 100